Mohammad Abufaraj
Papers
5
Total Citations
194
H-Index
4
About
Mohammad Abufaraj is a leading urologic oncologist whose research focuses on advancing surgical outcomes for bladder and kidney cancers, particularly through the comparative effectiveness of robot-assisted versus open surgery. His landmark international multicenter collaboration, analyzing over 2,400 patients, revealed significant trends in the adoption of robot-assisted radical cystectomy (RARC) and its impact on perioperative outcomes across North America and Europe. Abufaraj’s systematic reviews and meta-analyses have been instrumental in demonstrating that RARC offers comparable oncologic safety while potentially reducing complications and improving health-related quality of life for bladder cancer patients. His work on robot-assisted partial nephrectomy further explores ischemia techniques to preserve renal function in kidney cancer surgery. With his most cited paper garnering 82 references and several others exceeding 40 citations, Abufaraj’s contributions have shaped evidence-based guidelines and clinical decision-making. By rigorously evaluating real-world outcomes from major centers, he has provided urologists with critical data to optimize surgical approaches, ultimately enhancing patient recovery and long-term well-being.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5Robot-assisted partial nephrectomy2 citations · 2017